Dr. Reddy’s Laboratories disclosed the availability of an audio recording from its earnings call held on May 12, 2026, discussing financial results for the quarter ended March 31, 2026.
The company filed the notice with the National Stock Exchange of India, BSE Limited, New York Stock Exchange, and NSE IFSC in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The audio recording has been uploaded and made accessible to investors and stakeholders through the company’s official website. The link to the recording is provided at https://www.drreddys.com/cms/sites/default/files/2026-05/GMT20260512-140203_Recording.mp3, allowing interested parties to review the discussion between company management and financial analysts regarding quarterly performance.
K Randhir Singh, Company Secretary, Compliance Officer and Head of Corporate Social Responsibility at Dr. Reddy’s Laboratories, signed the regulatory notification on May 12, 2026, confirming the submission to stock exchange authorities.
Disclosure: This article is based on a regulatory filing submitted to the National Stock Exchange of India (NSE).